The Promise and Impact of the Next Generation of Weight Loss Drugs | Metaculus

Metaculus is a community dedicated to generating accurate predictions about future real-world events by aggregating the collective wisdom, insight, and intelligence of its participants.

Neuroscientist Stephan Guyenet writes about and researches eating behavior and health. He is the author of The Hungry Brain and is the founder and director of Red Pen Reviews. Obesity is a burden on individuals and on society, but it has historically been hard to treat. Until recently, weight loss approaches based on diet/lifestyle and drugs struggled to produce safe and sustainable weight loss of greater than 5% of body weight on average. That is changing with the development of highly effective, and apparently safe, new weight loss drugs. Which drugs will make it to patients, when will…

related reading

• Semaglutidonomicsastralcodexten.com
• Articles — Asimov Presspress.asimov.com
• Semaglutide & Its Friendspanpharmacon.substack.com
• How ‘miracle’ weight-loss drugs will change the worldnature.com
• Why Does Ozempic Cure All Diseases?astralcodexten.com
• The Worst Argument Against Ozempic - Cremieux Recueilcremieux.xyz
• Semaglutide - Wikipediaen.wikipedia.org
• The Ozempocalypse Is Nigh - by Scott Alexanderastralcodexten.com
• Retatrutide hits 28% weight loss in Phase 3chamath.substack.com
• A Chemical Hunger – Part I: Mysteries – SLIME MOLD TIME MOLDslimemoldtimemold.com
• If GLP-1 Drugs Are Good For Everything, Should We All Be on Them?derekthompson.org
• Beyond Steel Tanksasimov.press